Energy-enhanced parenteral nutrition and neurodevelopment of preterm newborns: A cohort study

Gianluca Terrin1, Giovanni Boscarino1, Corinna Gasparini1

  • 1Department of Maternal and Child Health, University of Rome La Sapienza, Rome, Italy.

Insights

Aggressive parenteral nutrition (PN) in preterm infants may negatively impact neurodevelopmental outcomes. Standard PN is associated with better motor and socioemotional skills at 24 months.

Area of Science:

  • Neonatology
  • Neurodevelopmental Pediatrics
  • Nutritional Science

Background:

  • Preterm infants face elevated risks for neurodevelopmental disabilities.
  • Aggressive parenteral nutrition (PN) is recommended to mitigate long-term consequences.
  • The impact of early energy-enhanced PN on long-term neurodevelopment requires further investigation.

Purpose of the Study:

  • To evaluate the long-term neurodevelopmental (NDV) effects of energy-enhanced parenteral nutrition (PN) in the first week of life for preterm neonates.
  • To compare neurodevelopmental outcomes at 24 months between preterm infants receiving energy-enhanced PN versus standard PN.

Main Methods:

  • A comparative study of two newborn cohorts (n=51) receiving either energy-enhanced PN (Group A) or energy-standard PN (Group B) for the first 7 days of life.
  • Both groups received equivalent protein amounts via PN.
  • Neurodevelopment at 24 months was assessed using the Bayley Scale of Infant Development-III edition.

Main Results:

  • Infants receiving standard PN (Group B) demonstrated significantly better gross motor, total scaled, and total composite motor scores (P < 0.05).
  • Group A (energy-enhanced PN) exhibited a higher incidence of delayed socioemotional competence (30.4% vs. 7.7%, P < 0.05).
  • No significant differences in growth parameters were observed at 24 months between groups. Linear regression indicated a negative association between early PN energy intake and motor/socioemotional scores.

Conclusions:

  • An aggressive parenteral nutrition strategy, particularly energy-enhanced, may lead to poorer motor and socioemotional outcomes in preterm infants at 24 months.
  • Increased caution is advised when implementing energy-enhanced PN protocols, especially for lower birth weight neonates.
  • Findings suggest a potential detrimental effect of high early energy PN on long-term neurodevelopment in preterm infants.
Abstract

Related Concept Videos

Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
428
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
431
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
387
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
678
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
80